News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
245,066 Results
Type
Article (20490)
Company Profile (110)
Press Release (224466)
Section
Business (78302)
Career Advice (813)
Deals (12404)
Drug Delivery (68)
Drug Development (24842)
Employer Resources (137)
FDA (4781)
Job Trends (6380)
News (121753)
Policy (9909)
Tag
Academia (1521)
Alliances (22816)
Alzheimer's disease (545)
Antibody-drug conjugate (ADC) (48)
Approvals (4753)
Artificial intelligence (76)
Bankruptcy (52)
Best Places to Work (5091)
Biosimilars (48)
Biotechnology (71)
Breast cancer (45)
Cancer (412)
Cardiovascular disease (42)
Career advice (717)
Cell therapy (95)
Clinical research (19097)
Collaboration (214)
COVID-19 (1046)
C-suite (58)
Data (414)
Diabetes (50)
Diagnostics (2659)
Earnings (20197)
Employer resources (117)
Events (33759)
Executive appointments (171)
FDA (4966)
Funding (175)
Gene therapy (73)
GLP-1 (299)
Government (1448)
Healthcare (5647)
Infectious disease (1087)
Inflammatory bowel disease (52)
Interviews (112)
IPO (4752)
Job creations (1474)
Job search strategy (634)
Layoffs (146)
Legal (2000)
Lung cancer (72)
Management (41)
Manufacturing (92)
Medical device (3426)
Medtech (3430)
Mergers & acquisitions (7759)
Metabolic disorders (168)
Neuroscience (667)
NextGen Class of 2024 (2199)
Non-profit (1696)
Northern California (528)
Obesity (107)
Opinion (88)
People (29045)
Phase I (5479)
Phase II (7941)
Phase III (7442)
Pipeline (150)
Postmarket research (756)
Preclinical (2814)
Press Release (62)
Radiopharmaceuticals (70)
Rare diseases (85)
Real estate (2901)
Recruiting (53)
Regulatory (6905)
Research institute (1305)
Resumes & cover letters (106)
Southern California (373)
Startups (2186)
United States (4460)
Vaccines (176)
Weight loss (85)
Date
Today (40)
Last 7 days (250)
Last 30 days (1269)
Last 365 days (13931)
2024 (12713)
2023 (15603)
2022 (20543)
2021 (22104)
2020 (20377)
2019 (17519)
2018 (12865)
2017 (12825)
2016 (12425)
2015 (13865)
2014 (10339)
2013 (8911)
2012 (9433)
2011 (9729)
2010 (9036)
Location
Africa (380)
Arizona (58)
Asia (27908)
Australia (3765)
California (1070)
Canada (487)
China (134)
Colorado (56)
Europe (36072)
Florida (135)
Illinois (99)
Indiana (88)
Japan (50)
Maryland (173)
Massachusetts (874)
Michigan (67)
Minnesota (98)
New Jersey (373)
New York (410)
North Carolina (264)
Northern California (528)
Ohio (46)
Pennsylvania (177)
South America (461)
Southern California (373)
Texas (139)
Washington State (89)
245,066 Results for "enzyvant sciences ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
Lobe Sciences Ltd., a biopharmaceutical company focused on developing transformative medicines to treat rare diseases and Clearway Global, LLC, a wholly owned subsidiary of Sancilio & Company, a pharmaceutical services company focused on value creation strategies, are pleased to announce a change in control of the Company and several enhancements to its ongoing growth strategy.
May 21, 2024
·
5 min read
Deals
Enzyvant Announces Merger with Altavant
Enzyvant Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of Sumitovant Biopharma Ltd., today announced a merger to form a biopharmaceutical company focused on delivering life-altering therapies for people with rare diseases.
December 6, 2022
·
8 min read
Business
StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update
StageZero Life Sciences announced its first quarter financial results for the three months ended March 31, 2024, and will provide an update on its business operations.
May 17, 2024
·
4 min read
Press Releases
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
November 18, 2024
·
7 min read
Deals
Specac, Ltd Acquires Harrick Scientific
Specac, Ltd announced today the acquisition of Harrick Scientific, Inc.
April 2, 2024
·
3 min read
Press Releases
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
September 12, 2024
·
4 min read
Press Releases
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors
November 15, 2024
·
2 min read
Press Releases
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
October 28, 2024
·
1 min read
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
Lobe Sciences Announces Update - June 04, 2024
Lobe Sciences Ltd., a biopharmaceutical company focused on developing transformative medicines to treat diseases with unmet medical needs and rare diseases announced the evaluation of strategic alternatives to improve shareholder value.
June 4, 2024
·
5 min read
1 of 24,507
Next
